AVAXIM Suspension for injection in a prefilled syringe Ref.[28228] Active ingredients: Hepatitis A, inactivated vaccine

Source: Υπουργείο Υγείας (CY)  Revision Year: 2021  Publisher: SANOFI PASTEUR, 14 Espace Henry Vallee, 69007 Lyon, France

Product name and form

AVAXIM 160 U, suspension for injection in prefilled syringe.

Hepatitis A vaccine (inactivated, adsorbed).

Pharmaceutical Form

Suspension for injection in a prefilled syringe.

The hepatitis A vaccine (inactivated, adsorbed) is a turbid and whitish suspension.

Qualitative and quantitative composition

One dose (0.5 ml) contains:

Hepatitis A virus, GBM strain* (inactivated): 160 ELISA units*

* Cultured on MRC-5 human diploid cells
** Adsorbed on hydrated aluminium hydroxide (0.3 milligrams of Al)
*** In the absence of an international standardised reference, the antigen content is expressed using an in-house reference.

Excipient(s) with known effect: Less than 1 mmol of sodium and less than 1 mmol of potassium per dose

Ethanol: 2.5 microlitres

Phenylalanine: 10 micrograms

Per 0.5 ml dose.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Hepatitis A, inactivated vaccine

Inactivated virus of a strain which was originally derived by further serial passage of a proven attenuated strain. The virus is grown, harvested, highly purified, formalin inactivated, and then adsorbed onto amorphous aluminum hydroxyphosphate sulphate.

List of Excipients

2-Phenoxyethanol, ethanol, formaldehyde, and Hanks 199 medium*, water for injections, polysorbate 80, hydrochloric acid and sodium hydroxide for pH adjustment.

* Hanks 199 medium (without phenol red) is a complex mixture of amino acids (including phenylalanine), mineral salts, vitamins, and other components, including potassium

Pack sizes and marketing

0.5 ml of suspension in prefilled syringe (type I glass) with a plunger stopper (chlorobutyl or bromobutyl), and an attached needle. Box of 1, 5, 10 or 20.

0.5 ml of suspension in prefilled syringe (type I glass) with a plunger stopper (chlorobutyl or bromobutyl), without needle. Box of 1 or 10.

0.5 ml of suspension in prefilled syringe (type I glass) with a plunger stopper (chlorobutyl or bromobutyl), with 1 or 2 separate needles. Box of 1 or 10.

All pack sizes may not be marketed.

Marketing authorization holder

SANOFI PASTEUR, 14 Espace Henry Vallee, 69007 Lyon, France

Marketing authorization dates and numbers

17602

Date of first authorisation: 13/03/1998
iDate of latest renewal: 12/05/2009

Drugs

Drug Countries
AVAXIM Brazil, Canada, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong, Ireland, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.